BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36766845)

  • 21. Sialic acid (SA)-modified selenium nanoparticles coated with a high blood-brain barrier permeability peptide-B6 peptide for potential use in Alzheimer's disease.
    Yin T; Yang L; Liu Y; Zhou X; Sun J; Liu J
    Acta Biomater; 2015 Oct; 25():172-83. PubMed ID: 26143603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of surfactant coated PLGA nanoparticles with in vitro human brain-like endothelial cells.
    Moya ELJ; Lombardo SM; Vandenhaute E; Schneider M; Mysiorek C; Türeli AE; Kanda T; Shimizu F; Sano Y; Maubon N; Gosselet F; Günday-Türeli N; Dehouck MP
    Int J Pharm; 2022 Jun; 621():121780. PubMed ID: 35504427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crossing the blood-brain barrier: Glutathione-conjugated poly(ethylene imine) for gene delivery.
    Englert C; Trützschler AK; Raasch M; Bus T; Borchers P; Mosig AS; Traeger A; Schubert US
    J Control Release; 2016 Nov; 241():1-14. PubMed ID: 27586188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
    Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
    Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silica Nanoparticles Decrease Glutamate Uptake in Blood-Brain Barrier Components.
    Sánchez-Cano F; Hernández-Kelly LC; Ortega A
    Neurotox Res; 2024 Mar; 42(2):20. PubMed ID: 38436780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of glutathione conjugation on the transcellular transport process of PEGylated liposomes across the blood brain barrier.
    Reginald-Opara JN; Tang M; Svirskis D; Chamley L; Wu Z
    Int J Pharm; 2022 Oct; 626():122152. PubMed ID: 36055442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Elvitegravir Nanoformulation Crosses the Blood-Brain Barrier and Suppresses HIV-1 Replication in Microglia.
    Gong Y; Zhi K; Nagesh PKB; Sinha N; Chowdhury P; Chen H; Gorantla S; Yallapu MM; Kumar S
    Viruses; 2020 May; 12(5):. PubMed ID: 32443728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overcoming Mfsd2a-Mediated Low Transcytosis to Boost Nanoparticle Delivery to Brain for Chemotherapy of Brain Metastases.
    Ju X; Miao T; Chen H; Ni J; Han L
    Adv Healthc Mater; 2021 May; 10(9):e2001997. PubMed ID: 33738958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide-mediated drug delivery across the blood-brain barrier for targeting brain tumors.
    Jafari B; Pourseif MM; Barar J; Rafi MA; Omidi Y
    Expert Opin Drug Deliv; 2019 Jun; 16(6):583-605. PubMed ID: 31107110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modeling Nanocarrier Transport across a 3D In Vitro Human Blood-Brain-Barrier Microvasculature.
    Lee SWL; Campisi M; Osaki T; Possenti L; Mattu C; Adriani G; Kamm RD; Chiono V
    Adv Healthc Mater; 2020 Apr; 9(7):e1901486. PubMed ID: 32125776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two peptides targeting endothelial receptors are internalized into murine brain endothelial cells.
    Hudecz D; Sigurdardóttir SB; Christensen SC; Hempel C; Urquhart AJ; Andresen TL; Nielsen MS
    PLoS One; 2021; 16(4):e0249686. PubMed ID: 33798235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcellular Model for Neutral and Charged Nanoparticles Across an In Vitro Blood-Brain Barrier.
    Zhang L; Fan J; Li G; Yin Z; Fu BM
    Cardiovasc Eng Technol; 2020 Dec; 11(6):607-620. PubMed ID: 33113565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational design of engineered H-ferritin nanoparticles with improved siRNA delivery efficacy across an
    Yuan Z; Wang B; Teng Y; Ho W; Hu B; Boakye-Yiadom KO; Xu X; Zhang XQ
    Nanoscale; 2022 May; 14(17):6449-6464. PubMed ID: 35416195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time-Dependent Internalization of Polymer-Coated Silica Nanoparticles in Brain Endothelial Cells and Morphological and Functional Effects on the Blood-Brain Barrier.
    Bittner A; Gosselet F; Sevin E; Dehouck L; Ducray AD; Gaschen V; Stoffel MH; Cho H; Mevissen M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
    De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
    J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virus-Inspired Glucose and Polydopamine (GPDA)-Coating as an Effective Strategy for the Construction of Brain Delivery Platforms.
    Duan Q; Liu R; Luo JQ; Zhang JY; Zhou Y; Zhao J; Du JZ
    Nano Lett; 2024 Jan; 24(1):402-410. PubMed ID: 38153842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transport of PEGylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and in vivo brain bioavailability.
    Rabanel JM; Piec PA; Landri S; Patten SA; Ramassamy C
    J Control Release; 2020 Dec; 328():679-695. PubMed ID: 32979453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functionalized PLGA nanoparticles prepared by nano-emulsion templating interact selectively with proteins involved in the transport through the blood-brain barrier.
    Monge M; Fornaguera C; Quero C; Dols-Perez A; Calderó G; Grijalvo S; García-Celma MJ; Rodríguez-Abreu C; Solans C
    Eur J Pharm Biopharm; 2020 Nov; 156():155-164. PubMed ID: 32927077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted delivery of rosmarinic acid across the blood-brain barrier for neuronal rescue using polyacrylamide-chitosan-poly(lactide-co-glycolide) nanoparticles with surface cross-reacting material 197 and apolipoprotein E.
    Kuo YC; Rajesh R
    Int J Pharm; 2017 Aug; 528(1-2):228-241. PubMed ID: 28549973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.